Alnylam Pharmaceuticals, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ALNY Nasdaq 2834 http://www.alnylam.com 71.19 Stock Down -0.79

Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alnylam Pharmaceuticals, Inc.

It's Official: Merck Now Owns Part of Alnylam - Mar 15th, 2014 7:32 am
Arrowhead Research Surges as It Advances Its Drug for Hepatitis B into Phase 2 - Mar 7th, 2014 12:31 pm
Sanofi-Regeneron Must Assess Risk in New Cholesterol Drug - Mar 7th, 2014 12:10 pm
Alnylam to Webcast Presentation at Barclays Global Healthcare Conference - Mar 6th, 2014 4:35 pm
Alnylam to Webcast Presentation at Barclays Global Healthcare Conference - Mar 6th, 2014 2:00 pm
Alnylam Announces Closing of Previously Announced Acquisition of Merck’s Sirna Therapeutics Subsidiary - Mar 6th, 2014 7:53 am
ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Regulation FD D - Mar 6th, 2014 6:22 am
Alnylam announces closing of previously announces acquisition of Merck unit - Mar 6th, 2014 6:09 am
Alnylam Announces Closing of Previously Announced Acquisition of Merck’s Sirna Therapeutics Subsidiary - Mar 6th, 2014 6:00 am
Arrowhead Research: 'Early Innings' for 'Major Story' - Mar 5th, 2014 9:50 am
The Zacks Analyst Blog Highlights: Sanofi, Alnylam Pharmaceuticals, Alexion Pharmaceuticals, Gilead Sciences and Amgen - Mar 4th, 2014 5:48 am
Alnylam Announces Closing of Previously Announced Alliance with Genzyme for Discovery, Development, and Commercialization of RNAi Therapeutics as Genetic Medicines - Feb 27th, 2014 5:43 pm
ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification t - Feb 27th, 2014 4:42 pm
Silence Therapeutics A Quieter Name In RNAi - Feb 27th, 2014 4:38 pm
Alnylam Announces Closing of Previously Announced Alliance with Genzyme for Discovery, Development, and Commercialization of RNAi Therapeutics as Genetic Medicines - Feb 27th, 2014 3:00 pm
ALNYLAM PHARMACEUTICALS, INC. Financials - Feb 27th, 2014 11:04 am
ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers - Feb 26th, 2014 5:32 am
Alnylam to Webcast Presentation at Cowen and Company 34th Annual Health Care Conference - Feb 25th, 2014 5:36 pm
Which Themes in Biotech Today are Bankable? - Feb 25th, 2014 4:32 pm
Alnylam to Webcast Presentation at Cowen and Company 34th Annual Health Care Conference - Feb 25th, 2014 2:00 pm